Cargando…
Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis
OBJECTIVES: To conduct systematic review and meta-analysis of interventional studies to investigate the impact of diabetes self-management education and support (DSMES) apps on adherence in patients with type 2 diabetes mellitus (T2D). METHODS: PubMed, Embase, CENTRAL, Web of Science, Scopus and Pro...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054079/ https://www.ncbi.nlm.nih.gov/pubmed/33853862 http://dx.doi.org/10.1136/bmjhci-2020-100291 |
_version_ | 1783680232796979200 |
---|---|
author | Enricho Nkhoma, Dumisani Jenya Soko, Charles Joseph Banda, Kondwani Greenfield, David Li, Yu-Chuan (Jack) Iqbal, Usman |
author_facet | Enricho Nkhoma, Dumisani Jenya Soko, Charles Joseph Banda, Kondwani Greenfield, David Li, Yu-Chuan (Jack) Iqbal, Usman |
author_sort | Enricho Nkhoma, Dumisani |
collection | PubMed |
description | OBJECTIVES: To conduct systematic review and meta-analysis of interventional studies to investigate the impact of diabetes self-management education and support (DSMES) apps on adherence in patients with type 2 diabetes mellitus (T2D). METHODS: PubMed, Embase, CENTRAL, Web of Science, Scopus and ProQuest were searched, in addition to references of identified articles and similar reviews. Experimental studies, reported in English, assessing DSMES app intervention’s impact on adherence and clinical outcomes of patients with T2D compared with usual care were included. Study bias was assessed using Cochrane Risk of Bias V.2.0 tool. Analysis plan involved narrative synthesis, moderator and meta-analysis. RESULTS: Six randomised controlled trials were included, involving 696 participants (average age 57.6 years, SD 10.59). Mobile apps were mostly used for imputing clinical data, dietary intake or physical activity, and transmitting information to the provider. At 3 months, DSMES apps proved effective in improving medication adherence (standardized mean difference (SMD)=0.393, 95% CI 0.17 to 0.61), glycated haemoglobin (HbA1c) (mean difference (MD)=−0.314, 95% CI −0.477 to –0.151) and Body Mass Index (BMI) (MD=−0.28, 95% CI −0.545 to –0.015). All pooled estimates had low heterogeneity (I(2) 0%). Four studies had moderate risk of bias while one each was judged to be low and high risks, respectively. CONCLUSION: DSMES apps had significant small to moderate effects on medication adherence, HbA1c and BMI of patients with T2D compared with usual care. Apps were described as reliable, easy to use and convenient, though participants were required to be phone literate. Evidence comes from feasibility trials with generally moderate risk of bias. Larger trials with longer follow-up periods using theory-based interventions are required to improve current evidence. |
format | Online Article Text |
id | pubmed-8054079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-80540792021-04-28 Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis Enricho Nkhoma, Dumisani Jenya Soko, Charles Joseph Banda, Kondwani Greenfield, David Li, Yu-Chuan (Jack) Iqbal, Usman BMJ Health Care Inform Review OBJECTIVES: To conduct systematic review and meta-analysis of interventional studies to investigate the impact of diabetes self-management education and support (DSMES) apps on adherence in patients with type 2 diabetes mellitus (T2D). METHODS: PubMed, Embase, CENTRAL, Web of Science, Scopus and ProQuest were searched, in addition to references of identified articles and similar reviews. Experimental studies, reported in English, assessing DSMES app intervention’s impact on adherence and clinical outcomes of patients with T2D compared with usual care were included. Study bias was assessed using Cochrane Risk of Bias V.2.0 tool. Analysis plan involved narrative synthesis, moderator and meta-analysis. RESULTS: Six randomised controlled trials were included, involving 696 participants (average age 57.6 years, SD 10.59). Mobile apps were mostly used for imputing clinical data, dietary intake or physical activity, and transmitting information to the provider. At 3 months, DSMES apps proved effective in improving medication adherence (standardized mean difference (SMD)=0.393, 95% CI 0.17 to 0.61), glycated haemoglobin (HbA1c) (mean difference (MD)=−0.314, 95% CI −0.477 to –0.151) and Body Mass Index (BMI) (MD=−0.28, 95% CI −0.545 to –0.015). All pooled estimates had low heterogeneity (I(2) 0%). Four studies had moderate risk of bias while one each was judged to be low and high risks, respectively. CONCLUSION: DSMES apps had significant small to moderate effects on medication adherence, HbA1c and BMI of patients with T2D compared with usual care. Apps were described as reliable, easy to use and convenient, though participants were required to be phone literate. Evidence comes from feasibility trials with generally moderate risk of bias. Larger trials with longer follow-up periods using theory-based interventions are required to improve current evidence. BMJ Publishing Group 2021-04-14 /pmc/articles/PMC8054079/ /pubmed/33853862 http://dx.doi.org/10.1136/bmjhci-2020-100291 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Enricho Nkhoma, Dumisani Jenya Soko, Charles Joseph Banda, Kondwani Greenfield, David Li, Yu-Chuan (Jack) Iqbal, Usman Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
title | Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
title_full | Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
title_fullStr | Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
title_full_unstemmed | Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
title_short | Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
title_sort | impact of dsmes app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054079/ https://www.ncbi.nlm.nih.gov/pubmed/33853862 http://dx.doi.org/10.1136/bmjhci-2020-100291 |
work_keys_str_mv | AT enrichonkhomadumisani impactofdsmesappinterventionsonmedicationadherenceintype2diabetesmellitussystematicreviewandmetaanalysis AT jenyasokocharles impactofdsmesappinterventionsonmedicationadherenceintype2diabetesmellitussystematicreviewandmetaanalysis AT josephbandakondwani impactofdsmesappinterventionsonmedicationadherenceintype2diabetesmellitussystematicreviewandmetaanalysis AT greenfielddavid impactofdsmesappinterventionsonmedicationadherenceintype2diabetesmellitussystematicreviewandmetaanalysis AT liyuchuanjack impactofdsmesappinterventionsonmedicationadherenceintype2diabetesmellitussystematicreviewandmetaanalysis AT iqbalusman impactofdsmesappinterventionsonmedicationadherenceintype2diabetesmellitussystematicreviewandmetaanalysis |